Crossmark

The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study

Crossref DOI link: https://doi.org/10.1007/s00384-018-3076-9

Published Online: 2018-05-21

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Eriksen, Ann Christina https://orcid.org/0000-0002-3905-4132
Sørensen, Flemming B.

Lindebjerg, Jan

Hager, Henrik

dePont Christensen, René

Kjær-Frifeldt, Sanne

Hansen, Torben F.
Funding

Funding for this research was provided by:

The Research Council of Lillebaelt Hospital (50.000)

The Danish Cancer Research Foundation. (127.000)
License Information

Text and Data Mining valid from 2018-05-21
More Information

Article History

Accepted: 2 May 2018

First Online: 21 May 2018

Compliance with ethical standards

: The study was approved by The Regional Committees on Health Research Ethics for Southern Denmark (S-20140119) and the Danish Data Protection Agency (14/26345). All patients were screened in the Danish Registry of Tissue Utilization before enrolment in the study.

: The authors declare that they have no conflict of interest.